Liabilities of Telix Pharmaceuticals Ltd from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
ifrs-full: USD and AUD
Summary
Telix Pharmaceuticals Ltd quarterly Liabilities in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • Telix Pharmaceuticals Ltd Liabilities for the quarter ending 31 Dec 2025 was $748,610,000, a 27% increase year-over-year.
Telix Pharmaceuticals Ltd quarterly Liabilities in AUD history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • Telix Pharmaceuticals Ltd Liabilities for the quarter ending 31 Dec 2024 was A$948,218,000, a 269% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Change (%)
Liabilities, Quarterly (AUD)
Liabilities, YoY Quarterly Change (%)

Telix Pharmaceuticals Ltd Quarterly Liabilities (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $748,610,000 +$161,168,000 +27% 31 Dec 2025 20-F 20 Feb 2026 2025 FY
Q4 2024 $587,442,000 +$412,829,000 +236% 31 Dec 2024 20-F 20 Feb 2026 2025 FY
Q4 2023 $174,613,000 31 Dec 2023 20-F 20 Feb 2026 2025 FY

Telix Pharmaceuticals Ltd Quarterly Liabilities (AUD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 A$948,218,000 +A$691,171,000 +269% 31 Dec 2024 20-F 24 Feb 2025 2024 FY
Q4 2023 A$257,047,000 31 Dec 2023 20-F 24 Feb 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.